As of 12:09pm ET
| +0.0004 / +0.11%|
The 3 analysts offering 12-month price forecasts for Cytori Therapeutics Inc have a median target of 2.50, with a high estimate of 5.00 and a low estimate of 1.00. The median estimate represents a +576.59% increase from the last price of 0.37.
The current consensus among 3 polled investment analysts is to Buy stock in Cytori Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.